108
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Plasma Interleukin-37 is Elevated in Acute Ischemic Stroke Patients and Probably Associated With 3-month Functional Prognosis 

, , , , , , , , & show all
Pages 1285-1294 | Published online: 04 Aug 2020

Figures & data

Table 1 Baseline Clinical Characteristics and Laboratory Data of the Study Population

Table 2 Plasma IL37 Levels in Different Stroke Subtypes

Figure 1 Plasma IL-37 levels of patients with AIS and normal control subjects. Horizontal lines represent median levels. P values indicate differences between groups determined by the Mann–Whitney U-test.

Figure 1 Plasma IL-37 levels of patients with AIS and normal control subjects. Horizontal lines represent median levels. P values indicate differences between groups determined by the Mann–Whitney U-test.

Figure 2 Plasma IL-37 levels in different stroke subtypes and normal control subjects. Horizontal lines in box plots represent median levels. Box areas represent the interquartile range, and whiskers indicate the minimum to maximum values. P values indicate differences between groups determined by Mann–Whitney U-test.

Figure 2 Plasma IL-37 levels in different stroke subtypes and normal control subjects. Horizontal lines in box plots represent median levels. Box areas represent the interquartile range, and whiskers indicate the minimum to maximum values. P values indicate differences between groups determined by Mann–Whitney U-test.

Figure 3 Correlation between plasma IL-37 level and lesion volumes. P values were determined using Spearman correlation analysis.

Figure 3 Correlation between plasma IL-37 level and lesion volumes. P values were determined using Spearman correlation analysis.

Figure 4 Correlation between plasma IL-37 level and NIHSS score. P values were determined using Spearman correlation analysis.

Figure 4 Correlation between plasma IL-37 level and NIHSS score. P values were determined using Spearman correlation analysis.

Table 3 Logistic Regression Analysis for Three Months Outcome

Figure 5 Plasma IL-37 levels of patients with favorable and unfavorable outcomes. Horizontal lines represent median levels. P values indicate differences between groups determined by the Mann–Whitney U-test.

Figure 5 Plasma IL-37 levels of patients with favorable and unfavorable outcomes. Horizontal lines represent median levels. P values indicate differences between groups determined by the Mann–Whitney U-test.